Udayavni Special

ICMR plans to set up registry of hospitalised COVID-19 patients


Team Udayavani, Aug 2, 2020, 1:59 PM IST

New Delhi: A registry of hospitalised COVID-19 patients across the country is being mooted to collect real time data which will help improve treatment outcomes, analyse trends in the progression of the pandemic and calibrate response, officials said.

The ICMR in collaboration with the Health Ministry and the AIIMS is planning to set up the National Clinical Registry which will help researchers and policy makers understand effectiveness of investigational therapies, adverse effects taking place and generate evidence for improving the treatment of COVID-19 patients.

“The aim is to collect data of the hospitalised COVID-19 patients like clinical and laboratory features, their demographics, comorbidities, treatment outcomes, complications in all age groups among others,” officials said.

The novel coronavirus, SARS-CoV-2 and the illness it is causing has so many unknown parameters that are a barrier to the proper understanding and management of the disease, they said.

“A systematically collected, comprehensive database covering different regions of the country will enable both researchers and policy makers to generate pertinent hypotheses, to inform crucial understanding of COVID 19, to detect trends in the progression of the pandemic and to accordingly calibrate response to the pandemic,” an official said.

Fifteen institutions of national repute including the Post Graduate Institute of Medical Education & Research (PGIMER) in Chandigarh, AIIMS Delhi, AIIMS Jodhpur, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru and Armed Force Medical College in Pune will connect with the hospitals and medical colleges to get them on board.

These 15 institutions would be the registry sites and would be mentoring around 100 COVID-19 hospitals which would be called satellite centres from where the data would be collected as part of the exercise.

The proposal has been sent for approval to the Central Ethics Committee on Human Research (CECHR) of the ICMR.

“The data will help improve the clinical management protocols as the repository would help us know which drug is working better in which age group, effectiveness of investigational therapies and adverse effects taking place. The idea is to generate evidence for improving the treatment of COVID-19 patients,” another official said.

Top News

Sushant Singh Rajput case: Maha slams CBI probe recommendation

UPSC announces 2019 civil services exam results, Pradeep Singh secures top position

US doing ”very well” against COVID-19, India has a ”tremendous problem”: Trump

Landslide on WEH after heavy rain, traffic movement affected

India’s COVID-19 tally climbs to 18,55,745; Recovery rate rises to 66.31 pc

175 ’eminent guests’ invited ‘bhoomi pujan’ after discussion with LK Advani, MM Joshi: Trust

Curfew imposed across Kashmir ahead of first anniversary of Article 370 revocation



Related Articles More

Disposed PPEs could be turned into biofuel, say Indian scientists

Hindutva now basic coat on canvas of Indian politics: Govindacharya

Sushant Singh Rajput case: Maha slams CBI probe recommendation

Pallakad: 3-year-old dies after wild elephant chases his father

Raigarh Police distributed 14L masks in 6 hrs, World record set

MUST WATCH

MGM college’s Ravindra Mantapa Opening Ceremony | Udayavani

Success story of Khajane Agricultural farm | Mangosteen Rambutan | Udayavani

Sushant Singh Rajput Death Mystery | Udayavani Straight Talk

Rangayya Naik | Life Lessons by Farmer | Udayavani

How To Grow Mangosteen Fruit | FULL INFORMATION

Latest Additions

2 Indians released from captivity in Afghanistan return to India

Hyundai Showroom hires street dog as car salesman

Why are Pulse oximeters a necessity amid Covid-19 pandemic and How does it work?

Players to be tested every 5th day during IPL, seven-day quarantine for kin who breaches bio-bubble

Pic of 15-foot unknown creature on sea shore goes viral

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.